Biggest News Aggregation in the World
📰 Medication Guide News

Page 23 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference

First study to assess histologic changes in the kidneys of patients with lupus nephritis treated with LUPKYNIS® Treatment was not associated with chronic injury, with the average chronicity... | May 9, 2023
United States United Kingdom Great Britain Greg Keenan European Union Aurinia Pharmaceuticals Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For Adults with Active Lupus Nephritis

Aurinia Pharmaceuticals Inc. today announced that the National Institute for Health and Care Excellence has recommended LUPKYNIS® as an option for treating adults with active lupus nephritis ... | May 3, 2023
United States United Kingdom Great Britain Peter Greenleaf Healthcare Products Regulatory Agency Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc.: Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS (Voclosporin) For Adults with Active Lupus Nephritis

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the National Institute for Health and Care Excellence (NICE) has recommended LUPKYNIS (voclosporin) as an option
United States United Kingdom Great Britain Peter Greenleaf Aurinia Pharmaceuticals National Institute For Health

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science